Met Life Investment Management, LLC Harrow Health, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 18,908 shares of HROW stock, worth $510,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,908
Previous 17,882
5.74%
Holding current value
$510,137
Previous $803,000
21.05%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HROW
# of Institutions
185Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$108 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$58 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$50.5 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$45.7 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$24.5 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $730M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...